Aspargo Labs, Inc. (“Aspargo Labs” or the “Company”), a pharmaceutical company commercializing an oral suspension spray technology, today announced it has submitted an application to the UK’s Medicine ...

Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a pharmaceutical company commercializing an oral suspension spray technology, today announced it has submitted ...

Medication can significantly improve the ability to initiate tasks, sustain attention, and complete responsibilities”— ...

Hormonal dysregulation and gut microbiota alterations as potential contributors to cognitive dysfunction CHINA, March ...

Mayo Clinic researchers have identified a rare mutation in the MET gene that can directly cause metabolic dysfunction-associated steatotic liver disease. The mutation disrupts the liver’s ability to ...

TMJ Plus Wellness Center is proud to announce that Dr. Becky Coats has completed advanced executive education in Artificial ...

When Bud Cauley’s car crashed in 2018, the damage was catastrophic. Six broken ribs. A collapsed lung. A fractured leg.

Pituitary neuroendocrine tumors (PitNETs) are commonly associated with visual disturbances and endocrine abnormalities; however, many patients also experience cognitive deficits, particularly in ...

Initiation of Phase 3 MASH trial planned for 2026Pemvidutide granted FDA Breakthrough Therapy Designation in MASH Topline data from RECLAIM Phase ...

Nominated KRRO-121 development candidate for the potential treatment of hyperammonemia in patients with urea cycle disorders and hepatic ...

The Trump administration is curbing animal experiments in response to shifts in public opinion, technological advances, years ...

Pharmacokinetic profile of the new, stable crystal form of neflamapimod largely overlaps with the therapeutically active drug product used in Phase 2b trial extension To ensure that plasma drug ...